Literature DB >> 21373776

Henoch-Schönlein purpura nephritis with nephrotic state in children: predictors of poor outcomes.

Hitoshi Wakaki1, Kenji Ishikura, Hiroshi Hataya, Yuko Hamasaki, Tomoyuki Sakai, Nahoko Yata, Tetsuji Kaneko, Masataka Honda.   

Abstract

Nephritis develops in 18-81% of Henoch-Schönlein purpura patients, and the long-term outcomes of this nephritis show great variation. A nephrotic state at disease onset has been proposed as a predictor of poor renal outcomes. We studied 42 children with Henoch-Schönlein purpura nephritis (HSPN) who presented with a nephrotic state during the early phase of the disease. The median age of the patients at the time of diagnosis was 7.4 years. The median follow-up period was 6.2 years. Twenty-five children (60%) made a complete recovery; nine (21%) progressed to end-stage renal disease. Multivariate logistic regression analyses revealed that the nephrotic state lasting for more than 3 months had a significant effect on renal outcomes (odds ratio 11.6; 95% confidential interval, 1.16-348.4; p = 0.03), whereas initial renal insufficiency, renal pathological findings, age at onset, and types of treatment did not. These findings indicate that clinical presentation, particularly duration of the nephrotic state, is related to long-term outcomes in HSPN patients with nephrosis. Our results also indicate that the therapeutic options for HSPN patients with a nephrotic state should be based on the clinical presentation rather than on the initial pathological findings alone.

Entities:  

Mesh:

Year:  2011        PMID: 21373776     DOI: 10.1007/s00467-011-1827-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  24 in total

1.  Long term renal prognosis of Henoch-Schönlein purpura in an unselected childhood population.

Authors:  M Stewart; J M Savage; B Bell; B McCord
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

2.  Prognosis of Henoch-Schönlein nephritis in children.

Authors:  R Counahan; M H Winterborn; R H White; J M Heaton; S R Meadow; N H Bluett; H Swetschin; J S Cameron; C Chantler
Journal:  Br Med J       Date:  1977-07-02

3.  Predictors of outcome in Henoch-Schönlein nephritis in children and adults.

Authors:  Rosanna Coppo; Simeone Andrulli; Alessandro Amore; Bruno Gianoglio; Giovanni Conti; Licia Peruzzi; Francesco Locatelli; Leonardo Cagnoli
Journal:  Am J Kidney Dis       Date:  2006-06       Impact factor: 8.860

Review 4.  Henoch-Schönlein nephritis in children and adults. Morphological features and clinicopathological correlations.

Authors:  P Rieu; L H Noël
Journal:  Ann Med Interne (Paris)       Date:  1999-02

5.  Factors affecting histological regression of crescentic Henoch-Schönlein nephritis in children.

Authors:  Jae Il Shin; Jee Min Park; Ji Hong Kim; Jae Seung Lee; Hyeon Joo Jeong
Journal:  Pediatr Nephrol       Date:  2005-11-04       Impact factor: 3.714

6.  Predictors of outcome in Henoch-Schönlein nephritis.

Authors:  Stella Edström Halling; Magnus P Söderberg; Ulla B Berg
Journal:  Pediatr Nephrol       Date:  2010-02-20       Impact factor: 3.714

7.  Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children.

Authors:  Outi Jauhola; Jaana Ronkainen; Olli Koskimies; Marja Ala-Houhala; Pekka Arikoski; Tuula Hölttä; Timo Jahnukainen; Jukka Rajantie; Timo Ormälä; Juha Turtinen; Matti Nuutinen
Journal:  Arch Dis Child       Date:  2010-09-18       Impact factor: 3.791

8.  Clinical outcome of Schönlein-Henoch purpura nephritis in children.

Authors:  K Schärer; R Krmar; U Querfeld; H Ruder; R Waldherr; F Schaefer
Journal:  Pediatr Nephrol       Date:  1999-11       Impact factor: 3.714

9.  The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents.

Authors:  G J Schwartz; L P Brion; A Spitzer
Journal:  Pediatr Clin North Am       Date:  1987-06       Impact factor: 3.278

10.  Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial.

Authors:  Claudio Pozzi; Simeone Andrulli; Lucia Del Vecchio; Patrizia Melis; Giovanni B Fogazzi; Paolo Altieri; Claudio Ponticelli; Francesco Locatelli
Journal:  J Am Soc Nephrol       Date:  2004-01       Impact factor: 10.121

View more
  23 in total

1.  Outcome of children with heavy non-nephrotic proteinuria in Henoch-Schönlein nephritis.

Authors:  Shuichiro Fujinaga; Amane Endo; Daishi Hirano
Journal:  Pediatr Nephrol       Date:  2011-11-11       Impact factor: 3.714

Review 2.  Pediatric vasculitis.

Authors:  Ezgi Deniz Batu; Seza Ozen
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

3.  Henoch-Schönlein nephritis with nephrotic state in children: predictors of poor outcomes.

Authors:  Hitoshi Wakaki; Kenji Ishikura
Journal:  Pediatr Nephrol       Date:  2011-11-15       Impact factor: 3.714

4.  The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch-Schönlein purpura nephritis.

Authors:  Mikael Koskela; Elisa Ylinen; Elli-Maija Ukonmaanaho; Helena Autio-Harmainen; Päivi Heikkilä; Jouko Lohi; Outi Jauhola; Jaana Ronkainen; Timo Jahnukainen; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2017-02-14       Impact factor: 3.714

5.  Mycophenolate mofetil following glucocorticoid treatment in Henoch-Schönlein purpura nephritis: the role of early initiation and therapeutic drug monitoring.

Authors:  Agnes Hackl; Jan U Becker; Lisa M Körner; Rasmus Ehren; Sandra Habbig; Eva Nüsken; Kai-Dietrich Nüsken; Kathrin Ebner; Max C Liebau; Carsten Müller; Martin Pohl; Lutz T Weber
Journal:  Pediatr Nephrol       Date:  2017-11-25       Impact factor: 3.714

6.  iTRAQ quantitative proteomic analysis differentially expressed proteins and signal pathways in henoch-schönlein purpura nephritis.

Authors:  Ran Gao; Xueli Niu; Lili Zhu; Ruiqun Qi; Liang He
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

7.  Treatment of children with Henoch-Schönlein purpura nephritis with mycophenolate mofetil.

Authors:  Yue Du; Ling Hou; Chengguang Zhao; Mei Han; Yubin Wu
Journal:  Pediatr Nephrol       Date:  2011-11-13       Impact factor: 3.714

8.  MiR-29b expression is altered in crescent formation of HSPN and accelerates Ang II-induced mesangial cell activation.

Authors:  Shan Cheng; Chun-Hua Zhu; Ai-Hua Zhang; Song-Ming Huang
Journal:  World J Pediatr       Date:  2019-10-19       Impact factor: 2.764

9.  Differences in pathological characteristics and laboratory indicators in adult and pediatric patients with Henoch-Schönlein purpura nephritis.

Authors:  Zhi Liu; Yu-Dan Wei; Yue Hou; Ying Xu; Xiu-Jiang Li; Yu-Jun Du
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

Review 10.  The path to chronic kidney disease following acute kidney injury: a neonatal perspective.

Authors:  Swasti Chaturvedi; Kar Hui Ng; Cherry Mammen
Journal:  Pediatr Nephrol       Date:  2016-01-25       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.